Strathmore Capital Advisors’s Labcorp LH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$677K Buy
2,566
+1
+0% +$271 0.19% 70
2025
Q4
$644K Sell
2,565
-11
-0.4% -$2.92K 0.21% 61
2025
Q3
$739K Sell
2,576
-176
-6% -$47.2K 0.3% 48
2025
Q2
$713K Buy
+2,752
New +$670K 0.32% 46

Other funds holding LH

Strathmore Capital Advisors's LH Position: Q1 2026 in Review

Strathmore Capital Advisors increased its Labcorp (LH) stake by 0.04% in Q1 2026, buying an estimated $271 and bringing the position to 2,566 shares worth $677K. The position accounts for 0.19% of the portfolio, ranked #70.

Strathmore Capital Advisors first reported a position in LH in Q2 2025 and has held it in 4 quarters since. The position peaked at $739K in Q3 2025. 1,031 funds tracked by Wall St. Rank hold LH as of Q1 2026.

  • Strathmore Capital Advisors held 2,566 shares of Labcorp worth $677K as of Q1 2026.
  • Strathmore Capital Advisors bought 1 Labcorp share in Q1 2026, an estimated $271.
  • Labcorp made up 0.19% of Strathmore Capital Advisors's portfolio in Q1 2026, its #70 holding.
  • Strathmore Capital Advisors first reported a position in Labcorp in Q2 2025 and has held it in 4 quarters since.
  • Strathmore Capital Advisors's Labcorp position peaked at $739K in Q3 2025.
  • 1,031 funds tracked by Wall St. Rank held Labcorp as of Q1 2026.

Based on Strathmore Capital Advisors's 13F filing for Q1 2026, filed 27 Apr 2026.